Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Venous thrombosis revisited

D P Thomas

    Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
    |September 1, 1996
    PubMed
    Summary
    This summary is machine-generated.

    Venous thromboembolism (VTE) is a serious risk for hospitalized patients. Genetic factors, like the factor V Leiden mutation, significantly increase VTE risk, especially when combined with surgery or pregnancy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effects of pericardiectomy on training- and myocardial infarction-induced left ventricular hypertrophy, chamber dimensions and gene expression.

    International journal of sports medicine·2016
    Same author

    Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1.

    Oncogene·2016
    Same author

    Introduction.

    Haemophilia : the official journal of the World Federation of Hemophilia·2016
    Same author

    Pharmacokinetic studies on a new purified factor IX concentrate.

    Haemophilia : the official journal of the World Federation of Hemophilia·2016
    Same author

    Clinical experience with a highly purified factor IX concentrate in patients undergoing surgical operations.

    Haemophilia : the official journal of the World Federation of Hemophilia·2016
    Same author

    Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1.

    Oncogene·2015
    Same journal

    Pampiniform venous plexus thrombosis in a 37 years-old male patient with severe thrombocytosis: a multifactorial aetiology.

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
    Same journal

    PROS1 Cys475Tyr mutation associated with a type III protein S deficiency pattern.

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
    Same journal

    Dynamic microclot profiling: thromboelastography advances precision management in long COVID and myalgic encephalomyelitis/chronic fatigue syndrome.

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
    Same journal

    Genetic characterization of Glanzmann thrombasthenia: insights from novel igta2b mutations in a Tunisian patient cohort.

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
    Same journal

    Uterine fibroids as an underrecognized risk factor for venous thromboembolism: a narrative review.

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
    Same journal

    SEER sonorheometry enhances fibrinolysis detection during liver transplantation with heparin.

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
    See all related articles

    Area of Science:

    • Medical Science
    • Genetics
    • Hematology

    Background:

    • Venous thromboembolism (VTE) is a major cause of illness and death in hospitalized individuals.
    • Deep vein stasis has long been considered a necessary but insufficient cause of thrombosis.
    • The discovery of the factor V Leiden mutation (Arg506) highlights the role of genetic factors in VTE pathogenesis.

    Discussion:

    • The factor V Leiden mutation impairs the anticoagulant function of activated protein C, increasing thrombin generation.
    • Surgical procedures, combined with stasis, can be a sufficient cause of VTE in individuals with impaired anticoagulant mechanisms.
    • Genetic predisposition plays a crucial role in the development of venous thrombosis.

    Key Insights:

    • The factor V Leiden mutation is prevalent in patients with VTE.

    Related Experiment Videos

  • Genetic screening for factor V Leiden may be beneficial for individuals with a history of VTE.
  • Understanding genetic risk factors is vital for VTE prevention strategies.

    • Outlook:

    • Screening for the factor V Leiden mutation is recommended for individuals with a personal or family history of VTE.
    • Pre-operative screening, screening during pregnancy, and before prescribing oral contraceptives are key considerations.
    • Further research into genetic predispositions can refine VTE risk assessment and management.